Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,501 | -69,920 | -72,849 | -69,456 | -76,247 |
| Depreciation Amortization | 363 | 1,380 | 1,404 | 1,427 | 1,753 |
| Accounts receivable | 1,375 | -633 | -424 | -453 | 413 |
| Other Working Capital | -10,023 | -2,829 | -18,233 | 29,243 | 925 |
| Other Operating Activity | 2,149 | 7,152 | 4,166 | 3,883 | 5,624 |
| Operating Cash Flow | $-39,637 | $-64,850 | $-85,936 | $-35,356 | $-67,532 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,216 | 23,130 | 132,270 | -74,430 | -11,869 |
| PPE Investments | 364 | -182 | -988 | -512 | -809 |
| Purchase Of Investment | N/A | N/A | -80,509 | N/A | N/A |
| Investing Cash Flow | $15,580 | $22,948 | $50,773 | $-74,942 | $-12,678 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,721 | 51,996 | 30,647 | 31,814 | 137,236 |
| Financing Cash Flow | $5,721 | $51,996 | $30,647 | $31,814 | $137,236 |
| Exchange Rate Effect | 14 | -49 | 25 | -22 | 5 |
| Beginning Cash Position | 36,330 | 26,285 | 30,776 | 109,282 | 52,251 |
| End Cash Position | 18,008 | 36,330 | 26,285 | 30,776 | 109,282 |
| Net Cash Flow | $-18,322 | $10,045 | $-4,491 | $-78,506 | $57,031 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,637 | -64,850 | -85,936 | -35,356 | -67,532 |
| Capital Expenditure | N/A | -182 | -1,008 | -512 | -809 |
| Free Cash Flow | -39,637 | -65,032 | -86,944 | -35,868 | -68,341 |